Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Lovo-cel
Pharma
FDA signs off on Vertex, CRISPR's gene therapy for sickle cell
Vertex and CRISPR have won FDA approval for sickle cell disease therapy Casgevy. The transformational treatment is a potential cure for the disease..
Kevin Dunleavy
Dec 8, 2023 12:31pm
Vertex's pricing won't affect bluebird's strategy on lovo-cel
Nov 7, 2023 3:20pm
Bluebird inks deal to sell lovo-cel FDA voucher for $103M
Oct 30, 2023 2:05pm
Bluebird's lovo-cel application finally lands at the FDA's desk
Apr 24, 2023 1:45pm
